Role of Bronchoscopy in Early Lung Cancer Screening of High Risk Population
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02277366|
Recruitment Status : Terminated (We have recruited some patients, but we haven't found any significant result by bronchoscopy in the high risk population.)
First Posted : October 29, 2014
Last Update Posted : November 16, 2015
|Condition or disease||Intervention/treatment|
|Lung Neoplasms||Procedure: Fluorescence Bronchoscopy/Narrow Band Bronchoscopy|
|Study Type :||Observational|
|Actual Enrollment :||400 participants|
|Observational Model:||Case Control|
|Official Title:||A Multi-center Randomized Control Study of Bronchoscopy in Early Lung Cancer Screening of High Risk Population|
|Study Start Date :||May 2015|
|Estimated Primary Completion Date :||November 2017|
|Estimated Study Completion Date :||November 2017|
Fluorescence/Narrow Band Bronchoscopy
All patients in the group are examined by Fluorescence Bronchoscopy and Narrow Band Bronchoscopy to make a early detection of lung cancer.
Procedure: Fluorescence Bronchoscopy/Narrow Band Bronchoscopy
Fluorescence Bronchoscopy and Narrow Band Bronchoscopy are used in the Fluorescence/Narrow Band Bronchoscopy group to make a diagnosis of lung cancer.
All patients in this group are examined by routine bronchoscopy to make a early detection of lung cancer.
- Diagnostic yield of Lung Cancer [ Time Frame: 1 week ]
- Number of Participants with Serious Adverse Events [ Time Frame: 1 week ]
- Cost of all examinations to make a diagnosis [ Time Frame: 2 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02277366
|Xi'an, Shaanxi, China, 710038|
|Principal Investigator:||Faguang Jin, Ph.D, MD||Tang-Du Hospital|